GlassScriptPhysician profile
Jose Valladares
NPI 1053303255
$13,276.31
in general payments reported to CMS, 2019-2025
71 companies · $3,161 in 2025
The $3,161 reported for 2025 was more than what 75% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,304 · 2020: $983 · 2021: $848 · 2022: $1,403 · 2023: $1,494 · 2024: $4,083 · 2025: $3,161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,196 · Education: $542.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,195.67 |
| Education | $541.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,197.91 | 2019-2025 | Darzalex, Rybrevant, Erleada |
| Pfizer INC. | $1,028.18 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $1,021.07 | 2019-2025 | Keytruda, Welireg, Lynparza |
| Novartis Pharmaceuticals Corporation | $859.45 | 2020-2025 | |
| Sobi, INC | $801.90 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $610.30 | 2019-2025 | Opdivo, Opdualag |
| Amgen INC. | $576.99 | 2019-2023 | Nplate, Xgeva, Lumakras |
| Astrazeneca Pharmaceuticals LP | $556.28 | 2023-2025 | Imfinzi, Enhertu, Lynparza |
| Celgene Corporation | $420.49 | 2021-2025 | Reblozyl, Opdualag, Pomalyst |
| Incyte Corporation | $402.21 | 2019-2025 | Jakafi, Monjuvi, Zynyz |
| Emd Serono, INC. | $399.67 | 2020-2025 | Bavencio |
| Eisai INC. | $380.04 | 2019-2025 | |
| Astellas Pharma US INC | $309.22 | 2020-2025 | Vyloy, Padcev, Xospata |
| Abbvie INC. | $277.24 | 2023-2025 | Venclexta |
| Genentech USA, INC. | $263.23 | 2019-2025 | Tecentriq, Phesgo, Tecentriq Hybreza |
Show all 71 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $254.87 | 2022-2025 | Enhertu, Injectafer |
| Glaxosmithkline, LLC. | $225.52 | 2021-2025 | Ojjaara, Jemperli, Zejula |
| Azurity Pharmaceuticals, INC. | $200.52 | 2025 | Danziten, Vivimusta |
| Lilly USA, LLC | $178.70 | 2020-2025 | Verzenio, Jaypirca, Retevmo |
| Springworks Therapeutics, INC. | $163.93 | 2024-2025 | Ogsiveo |
| Takeda Pharmaceuticals U.S.A., INC. | $137.56 | 2024-2025 | Hyqvia, Iclusig, Fruzaqla |
| Jazz Pharmaceuticals INC. | $136.69 | 2021-2025 | |
| Apellis Pharmaceuticals, INC. | $136.16 | 2023 | Empaveli |
| Puma Biotechnology, INC. | $122.19 | 2020-2024 | |
| Servier Pharmaceuticals LLC | $121.24 | 2024-2025 | Voranigo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $121.15 | 2019-2025 | Gilotrif |
| Exelixis INC. | $110.79 | 2020-2025 | Cabometyx |
| Kite Pharma, INC. | $109.86 | 2020-2025 | Yescarta |
| Janssen Pharmaceuticals, INC | $106.03 | 2019-2020 | |
| Genmab U.S., INC. | $101.85 | 2024-2025 | Tivdak, Epkinly |
| Bayer Healthcare Pharmaceuticals INC. | $97.10 | 2020-2025 | |
| Tersera Therapeutics LLC | $93.80 | 2024-2025 | Xermelo |
| Verastem, INC. | $91.96 | 2019 | |
| Gilead Sciences, INC. | $90.98 | 2022-2024 | |
| Syndax Pharmaceuticals, INC. | $89.66 | 2025 | |
| Genzyme Corporation | $83.47 | 2021-2025 | |
| Mirati Therapeutics, INC. | $76.29 | 2024 | Krazati |
| Aveo Pharmaceuticals, INC. | $76.06 | 2021-2023 | Fotivda |
| Deciphera Pharmaceuticals INC. | $73.92 | 2024 | Qinlock, Tgct |
| Karyopharm Therapeutics INC. | $69.03 | 2021-2025 | Xpovio |
| Osiris Therapeutics INC. | $68.25 | 2019 | |
| Beigene USA, INC. | $66.12 | 2020-2024 | Brukinsa |
| Array Biopharma INC | $62.77 | 2024-2025 | Lorbrena, Braftovi, Mektovi |
| Novocure INC. | $60.71 | 2024-2025 | Optune Lua (Novottf-200t) |
| Agios Pharmaceuticals, INC. | $53.84 | 2025 | Pyrukynd |
| Dova Pharmaceuticals | $49.44 | 2020-2021 | |
| Iovance Biotherapeutics, INC. | $48.77 | 2025 | Amtagvi |
| Taiho Oncology, INC. | $48.28 | 2022-2024 | |
| Medtronic, INC. | $47.83 | 2023 | Osteocool Rf Ablation System |
| Tempus Ai, INC | $46.93 | 2024 | |
| Alexion Pharmaceuticals, INC. | $45.52 | 2024-2025 | Ultomiris |
| Regeneron Healthcare Solutions, INC. | $42.27 | 2021-2023 | Libtayo |
| Stemline Therapeutics INC. | $40.60 | 2025 | Orserdu |
| Beone Medicines USA, INC. | $39.24 | 2025 | Brukinsa |
| Octapharma USA, INC. | $36.24 | 2024 | Octagam Immune Globulin (Human) |
| Legend Biotech USA INC. | $36.21 | 2025 | Carvykti |
| Shield Therapeutics INC | $34.59 | 2024 | |
| Immunocore Limited | $29.88 | 2024 | Kimmtrak |
| Rigel Pharmaceuticals, INC. | $28.93 | 2025 | Gavreto, Rezlidhia, Tavalisse |
| Recordati_rare_diseases_inc. | $24.20 | 2024 | Sylvant |
| Progenics Pharmaceuticals, INC. | $23.77 | 2024 | |
| Boston Scientific Corporation | $23.45 | 2024 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Accord Healthcare, INC. | $21.40 | 2025 | |
| Myovant Sciences INC. | $19.27 | 2022 | |
| Blueprint Medicines Corporation | $18.00 | 2024 | Ayvakit |
| Siemens Medical Solutions USA, INC. | $16.43 | 2022 | |
| Coherus Oncology, INC. | $15.59 | 2023 | |
| Adc Therapeutics America, INC. | $15.48 | 2023 | |
| Pharmacyclics LLC, An Abbvie Company | $14.45 | 2020 | |
| Cti Biopharma Corp. | $13.43 | 2022 | |
| Secura Bio, INC. | $10.91 | 2022 |
Drugs and devices associated with these payments
Doptelet $758Keytruda $484Imfinzi $420Darzalex $308Rybrevant $308Enhertu $281Lenvima $268Danziten $201Imbruvica $168Ogsiveo $164Ojjaara $157Jakafi $147Reblozyl $139Welireg $137Empaveli $136Lynparza $134Fabhalta $132Erleada $131Adcetris $123Elrexfio $123Zepzelca $121Scemblix $117Bosulif $115Tecentriq $101Epkinly $94.99Xermelo $93.80Yescarta $89.13Padcev $88.24Opdivo $86.73Brukinsa $85.20Cabometyx $84.41Tivdak $83.06Paxlovid $82.97Tasigna $76.33Krazati $76.29Xtandi $75.53Qinlock $73.92Kisqali $72.92Nplate $70.87Xgeva $70.87Jaypirca $69.34Verzenio $69.34Ibrance $67.64Talvey $64.73Tecvayli $64.73Gilotrif $64.06Lumakras $63.15Lorbrena $62.77Orgovyx $61.84Elahere $61.35Pluvicto $61.34Monjuvi $61.28Optune Lua (Novottf-200t) $60.71Fotivda $60.30Opdualag $59.98Vyloy $56.91Nubeqa $54.08Pyrukynd $53.84Vectibix $52.18Sarclisa $51.41Hyqvia $50.43Xpovio $49.22Voranigo $49.13Amtagvi $48.77Comirnaty $48.04Osteocool Rf Ablation System $47.83Iclusig $45.94Talzenna $45.63Ultomiris $45.52Oxbryta $44.66Tgct $42.61Carvykti $41.72Venclexta $41.21Orserdu $40.60Zynyz $37.76Octagam Immune Globulin (Human) $36.24Braftovi $35.48Mektovi $35.48Accrufer $34.59Jemperli $33.45Phesgo $30.20Kimmtrak $29.88Synagis $29.85Tavalisse $28.93Rezlidhia $28.93Gavreto $28.93Inqovi $28.14Lonsurf $28.14Libtayo $25.69Pomalyst $24.41Sylvant $24.20Keytruda Qlex $23.97Pylarify $23.77Emrelis $23.51Tibsovo $23.49Therasphere Y90 Glass Microspheres 10 Gbq $23.45Fruzaqla $23.05Retevmo $22.75Eliquis $22.54Akeega $22.17
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Valladares listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.